Federal Circuit to re-hear biotech cases post-Bilski
The Supreme Court on Monday issued orders granting certiorari, and then vacating and remanding, both Prometheus v Mayo and Classen v Biogen in light of this week’s Bilski decision
mean the Federal Circuit will try the cases again under the new standards set forth by the High Court in
Both cases have been closely watched by the biotechnology community.
Classen v Biogen
, a patent covering...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.